23andMe Bankruptcy: What Happens to Your DNA Data?

The Rise and Fall of 23andMe

• 💡 Founded in 2006, 23andMe offered a tantalizing idea: spit into a tube and learn about family history and health risks.
• 🚀 The company went public in 2021 with a $3.5 billion valuation, attracting significant Wall Street support.
• 📉 However, 23andMe has struggled financially, failing to turn a profit since its IPO and experiencing declining sales and stock price.

Bankruptcy and Data Sale

• 📌 On March 23rd, 23andMe filed for bankruptcy, with its most valuable asset, customer genetic data, now up for sale.
• ⚠️ Privacy experts and state attorneys general are urging users to delete their data due to concerns about who might acquire it and how it could be used.
• 🧬 Unlike other data breaches, DNA cannot be changed, making the potential sale of genetic information particularly unsettling.

User Concerns and Protections

• 💬 Many users, like Jonathan Randles' mother, did not read the terms of service and were unaware their genetic data could be sold.
• 🚫 While bankruptcy rules prevent the use of genetic data for employment or general healthcare decisions, it may still be used for life or disability insurance and targeted advertising.
• ⚖️ A privacy ombudsman and the US Trustee will provide oversight in the bankruptcy process, ensuring more transparency than a typical data sale.

Precedent and Future Implications

• 🤝 In a previous bankruptcy, a genetic testing company was sold to LabCorp, with potential uses for creating new treatments and for healthcare purposes.
• 📜 23andMe's terms of service do permit the transfer of data in the event of bankruptcy or acquisition.
• 🔍 This situation highlights the importance of users understanding terms of service, especially regarding the value and potential sale of personal genetic information.